Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 13, 2023New England Journal of MedicineOpen Access

Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults

View Full Paper
Ask AI
Bookmark
Share

Authors

EWEleanor WilsonModerna Therapeutics (United States)JGJaya GoswamiModerna Therapeutics (United States)ABAbdullah H BaquiJohns Hopkins University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wilson et al. (2023) studied this question.

synapsesocial.com/papers/69d89b7d8cb8f39931ae35ddhttps://doi.org/10.1056/nejmoa2307079
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Age related differences in humoral immune response to respiratory syncytial virus infection in adults2004 · 61 citations
  2. 2Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-20182022 · 252 citations
  3. 3A proof of concept for structure-based vaccine design targeting RSV in humans2019 · 345 citations
  4. 4Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults2005 · 2,275 citations
  5. 5Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study2020 · 155 citations